about
Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial ResistanceDissemination of carbapenemases producing Gram negative bacteria in the Middle EastA Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae.CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals.Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey.Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other AntibioticsOxidative Stress Induced by Polymyxin E Is Involved in Rapid Killing of Paenibacillus polymyxa.Current methods for the identification of carbapenemases.Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest IranEpidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis.New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.The Prevalence of CTX-M-15 Extended-spectrum β-Lactamases Among Salmonella spp. and Shigella spp. Isolated from three Iranian Hospitals.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Evaluation of photodynamic therapy effect along with colistin on pandrug-resistant Acinetobacter baumannii.Draft Whole-Genome Assemblies of Drug-Resistant Clinical Isolates of Klebsiella pneumoniae from the Philippines.In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques.The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions.Acquisition of Broad-Spectrum Cephalosporin Resistance Leading to Colistin Resistance in Klebsiella pneumoniae.Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in KoreaFrequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation.Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin in Salmonella enterica.A Dual Role of P53 in Regulating Colistin-Induced Autophagy in PC-12 Cells.In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital.Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article.Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from Northwest of Iran.Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii.Colistin: revival in times of hardship.A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae.Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations.Heterogeneous and Flexible Transmission of mcr-1 in Hospital-Associated Escherichia coli.Community-Acquired Urinary Tract Infection by in the Era of Antibiotic ResistanceSynergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens and
P2860
Q26749601-E5CBD315-DD75-4638-B983-7E5199BC2FC0Q26771490-4C0DB38C-DF6E-4DC7-AE9D-E3E2701E4670Q33755535-E5BBF10C-62E9-46D3-8481-9FC5082C3FFDQ34552966-29DA9646-1AEF-488C-B3CA-4FB7CE72CBBBQ36290895-39D99CF1-0EA7-4E96-946F-16E346B2A000Q36834752-501BC6F7-F68C-418D-90B7-DB68B083FE93Q36933507-063D93D6-D0D1-4C17-A02A-E6232C5367E5Q37053548-E1140EAD-6341-4C55-ABA9-DEE7B767D6C9Q37119083-0CFECA22-1818-4415-97D2-AA174ACA447DQ37328056-36034208-6FCD-4DD6-9825-C0CCF3C19CFCQ37358713-730EEE63-321C-48B1-9B16-C896C509935DQ37685688-9246C796-E64E-4897-BF49-4C982F2B9B51Q38563315-A9BF8DC6-1784-42B5-8B64-D34E68F7BD99Q38626784-E7BDF154-43AE-436A-B883-91D1B39CDEE6Q38722054-1D8A091A-6455-4562-BE30-6C0D36840ABDQ38805100-1648414B-EB50-4DC1-9428-E8ABBC021140Q38908394-3E0DC861-F9BA-4448-8C4E-2DA78149394CQ39333751-42BB6444-E416-4A3E-BE38-2826AF1EB87BQ40102922-694715D9-02A6-411E-9F2F-84984E95ED76Q40135459-D73280E0-5263-467F-B325-9A4CDF144B97Q40179477-59FD6E2A-6569-48D0-B5CB-C5895DE461BBQ40519553-CFCBBA05-5B52-4FD8-B37B-DEAAE4279E20Q40866563-9D035C57-4D21-4477-BA33-FDFDF5112503Q42335975-B72B4980-4EB0-4A57-BD5E-1D11FEB40DC0Q46007524-69B41BAD-2B35-4CE4-A510-C777AB8D2869Q46522626-385701A0-8D7F-4962-824E-0B38731F8959Q47101924-643DCA0F-EE11-48FB-8C4C-54CAAC389A7CQ47135799-9AE1D728-DB7B-4301-BC20-E0C80006CF9FQ49222168-AB63A72B-E768-41F5-A186-A811EDB5A93CQ50318621-EFA95595-ED9A-465C-B74D-92C8414E0A93Q50933851-D71E0783-2814-445E-9E64-4675F8A53300Q51531010-6108B624-34FB-4986-B22E-1033063F3AF1Q53704505-C45B3BD4-A157-496B-B411-00CC246EB81AQ55368723-6FB0769F-3E61-4EE4-831D-927E17A38944Q55433450-10CCE46A-AC58-4968-97EF-98F702DFC17DQ57821217-F6A2C157-1773-43AC-B0D5-AAD22FA88A02Q58781151-9F185266-8B8C-48A8-BD32-882582D9FB55
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Colistin, mechanisms and prevalence of resistance.
@ast
Colistin, mechanisms and prevalence of resistance.
@en
Colistin, mechanisms and prevalence of resistance.
@nl
type
label
Colistin, mechanisms and prevalence of resistance.
@ast
Colistin, mechanisms and prevalence of resistance.
@en
Colistin, mechanisms and prevalence of resistance.
@nl
prefLabel
Colistin, mechanisms and prevalence of resistance.
@ast
Colistin, mechanisms and prevalence of resistance.
@en
Colistin, mechanisms and prevalence of resistance.
@nl
P1476
Colistin, mechanisms and prevalence of resistance.
@en
P2093
Abed Zahedi Bialvaei
P304
P356
10.1185/03007995.2015.1018989
P407
P577
2015-03-19T00:00:00Z